Switching from Nortriptyline to Sertraline

Key Safety Considerations

The American Academy of Child and Adolescent Psychiatry guidelines state that caution should be exercised when combining two or more non-MAOI serotonergic drugs, including TCAs and SSRIs, due to the risk of serotonin syndrome 1
Serotonin syndrome symptoms include mental status changes, neuromuscular hyperactivity, and autonomic hyperactivity, and can be fatal if left untreated 2, 3
Symptoms of serotonin syndrome typically arise within 24-48 hours after combining serotonergic medications 1, 2

The American Academy of Child and Adolescent Psychiatry recommends starting sertraline at a low dose (25 mg/day) and titrating slowly to minimize the risk of serotonin syndrome 1, 2
The dose of sertraline should be increased slowly, with increments at approximately 1-2 week intervals, given its shorter half-life 4, 5
Patients should be monitored intensively for symptoms of serotonin syndrome, especially in the first 24-48 hours after dosage changes 1, 2

The American College of Cardiology guidelines note that caution should be exercised when using TCAs, such as nortriptyline, in patients with cardiac disease or dysrhythmia history 6, 7
Sertraline can interact with drugs metabolized by CYP2D6, although this is less relevant for the switch itself 4, 5

Patients should be instructed to immediately report symptoms of serotonin syndrome, including confusion, agitation, anxiety, tremors, muscle twitching, fever, sweating, rapid heart rate, diarrhea, or shivering 2, 4, 7
If serotonin syndrome develops, all serotonergic agents should be discontinued immediately, and supportive care with continuous cardiac monitoring should be provided 2